6336 related articles for article (PubMed ID: 2677917)
1. Molecular cloning of the breakpoint region on chromosome 6 in cutaneous malignant melanoma: evidence for deletion in the c-myb locus and translocation of a segment of chromosome 12.
Dasgupta P; Linnenbach AJ; Giaccia AJ; Stamato TD; Reddy EP
Oncogene; 1989 Oct; 4(10):1201-5. PubMed ID: 2677917
[TBL] [Abstract][Full Text] [Related]
2. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
Tantravahi R; Dudek H; Patel G; Reddy EP
Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
[TBL] [Abstract][Full Text] [Related]
3. Alterations at the rel locus in human lymphoma.
Lu D; Thompson JD; Gorski GK; Rice NR; Mayer MG; Yunis JJ
Oncogene; 1991 Jul; 6(7):1235-41. PubMed ID: 1650444
[TBL] [Abstract][Full Text] [Related]
4. Microdissection based cloning of a translocation breakpoint in a human malignant melanoma.
Zhang J; Cui P; Glatfelter AA; Cummings LM; Meltzer PS; Trent JM
Cancer Res; 1995 Oct; 55(20):4640-5. PubMed ID: 7553642
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of human melanoma cell growth and tumor suppression by chromosome 6.
Robertson GP; Coleman AB; Lugo TG
Cancer Res; 1996 Apr; 56(7):1635-41. PubMed ID: 8603413
[TBL] [Abstract][Full Text] [Related]
6. Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma.
Trent JM; Thompson FH; Meyskens FL
Cancer Res; 1989 Jan; 49(2):420-3. PubMed ID: 2642739
[TBL] [Abstract][Full Text] [Related]
7. C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences.
Vellard M; Soret J; Viegas-Pequignot E; Galibert F; Nguyen VC; Dutrillaux B; Perbal B
Oncogene; 1991 Apr; 6(4):505-14. PubMed ID: 1840680
[TBL] [Abstract][Full Text] [Related]
8. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).
Langezaal SM; Graadt van Roggen JF; Cleton-Jansen AM; Baelde JJ; Hogendoorn PC
Br J Cancer; 2001 Feb; 84(4):535-8. PubMed ID: 11207050
[TBL] [Abstract][Full Text] [Related]
9. Chromosome locations of the MYB related genes, AMYB and BMYB.
Barletta C; Druck T; LaForgia S; Calabretta B; Drabkin H; Patterson D; Croce CM; Huebner K
Cancer Res; 1991 Jul; 51(14):3821-4. PubMed ID: 2065336
[TBL] [Abstract][Full Text] [Related]
10. The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma.
Ren S; Smith MJ; Louro ID; McKie-Bell P; Bani MR; Wagner M; Zochodne B; Redden DT; Grizzle WE; Wang Nd; Smith DI; Herbst RA; Bardenheuer W; Opalka B; Schütte J; Trent JM; Ben-David Y; Ruppert JM
Oncogene; 2000 Mar; 19(11):1419-27. PubMed ID: 10723133
[TBL] [Abstract][Full Text] [Related]
11. Identification of alternatively spliced transcripts for human c-myb: molecular cloning and sequence analysis of human c-myb exon 9A sequences.
Dasgupta P; Reddy EP
Oncogene; 1989 Dec; 4(12):1419-23. PubMed ID: 2687764
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous malignant melanoma and atypical moles associated with a constitutional rearrangement of chromosomes 5 and 9.
Petty EM; Bolognia JL; Bale AE; Yang-Feng T
Am J Med Genet; 1993 Jan; 45(1):77-80. PubMed ID: 8418665
[TBL] [Abstract][Full Text] [Related]
13. The t(6;16)(p21;q22) chromosome translocation in the LNCaP prostate carcinoma cell line results in a tpc/hpr fusion gene.
Veronese ML; Bullrich F; Negrini M; Croce CM
Cancer Res; 1996 Feb; 56(4):728-32. PubMed ID: 8631004
[TBL] [Abstract][Full Text] [Related]
14. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma.
Parris CN; Harris JD; Griffin DK; Cuthbert AP; Silver AJ; Newbold RF
Cancer Res; 1999 Feb; 59(3):516-20. PubMed ID: 9973191
[TBL] [Abstract][Full Text] [Related]
15. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
16. BCL2 complex rearrangement in follicular lymphoma: translocation mbr/JH and deletion in the vcr region of the same BCL2 allele.
Séité P; Hillion J; d'Agay MF; Berger R; Larsen CJ
Oncogene; 1993 Nov; 8(11):3073-80. PubMed ID: 8414508
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor.
Pujana MA; Ruiz A; Badenas C; Puig-Butille JA; Nadal M; Stark M; Gómez L; Valls J; Solé X; Hernández P; Cerrato C; Madrigal I; de Cid R; Aguilar H; Capellá G; Cal S; James MR; Walker GJ; Malvehy J; Milà M; Hayward NK; Estivill X; Puig S
Genes Chromosomes Cancer; 2007 Feb; 46(2):155-62. PubMed ID: 17099875
[TBL] [Abstract][Full Text] [Related]
18. Identification of a second promoter in the human c-myb proto-oncogene.
Jacobs SM; Gorse KM; Westin EH
Oncogene; 1994 Jan; 9(1):227-35. PubMed ID: 8302584
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of a t(8;14)(q24;q11) translocation juxtaposing c-myc and TcR-alpha genes in a T-cell leukaemia: involvement of a V alpha internal heptamer.
Bernard O; Larsen CJ; Hampe A; Mauchauffé M; Berger R; Mathieu-Mahul D
Oncogene; 1988 Feb; 2(2):195-200. PubMed ID: 2966921
[TBL] [Abstract][Full Text] [Related]
20. Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS.
Testa JR; Park M; Blair DG; Kalbakji A; Arden K; Vande Woude GF
Oncogene; 1990 Oct; 5(10):1565-71. PubMed ID: 2250912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
